Annual report pursuant to Section 13 and 15(d)

CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY [Parenthetical]

v3.10.0.1
CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY [Parenthetical] - USD ($)
12 Months Ended
Dec. 31, 2017
Dec. 31, 2016
Accrued Liabilities   $ 374,000
Debt Conversion, Converted Instrument, Shares Issued 60,000  
Payments of Stock Issuance Costs $ 695,000  
Celleration, Inc [Member]    
Accrued Liabilities   675,000
Debt Conversion, Converted Instrument, Shares Issued 101,243  
Choice Therapeutics [Member]    
Accrued Liabilities   $ 500,000
Debt Conversion, Converted Instrument, Shares Issued 131,579